Education
About Us
Working with TipRanks
Follow Us
Swiss Re (SSREY)
OTHER OTC:SSREY
SSREY Stock Chart & Stats
$46.14
$0.33(0.89%)
At close: 4:00 PM EST
$46.14
$0.33(0.89%)
Day’s Range― - ―
52-Week Range$37.67 - $48.50
Previous CloseN/A
Volume3.75K
Average Volume (3M)6.68K
Market Cap
$45.10B
Enterprise Value$54.38B
Total Cash (Recent Filing)$96.26B
Total Debt (Recent Filing)$9.58B
Price to Earnings (P/E)10.5
Beta0.56
Next Earnings
May 07, 2026EPS Estimate
0.91Next Dividend Ex-DateN/A
Dividend Yield4.42%
Share Statistics
EPS (TTM)0.57
Shares Outstanding1,195,046,900
10 Day Avg. Volume9,895
30 Day Avg. Volume6,678
Financial Highlights & Ratios
PEG Ratio4.11
Price to Book (P/B)1.92
Price to Sales (P/S)0.95
P/FCF Ratio14.14
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue1.16
Enterprise Value/Gross Profit1.67
Enterprise Value/Ebitda6.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3.96
Revenue Forecast (FY)$43.69B
Bulls Say, Bears Say
Bulls Say
P&C Underwriting StrengthSustained low combined ratios in P&C demonstrate disciplined underwriting and pricing power versus peers. Over the next 2–6 months this structural advantage supports predictable underwriting margins, capital retention after losses, and a durable earnings base through cycles.
High Return On EquityA strong ROE indicates efficient use of shareholder capital and robust profitability generation. Persistently high ROE enables reinvestment in business lines, supports dividend capacity and capital buffers, and signals lasting capital efficiency relative to many insurers.
Positive Free Cash Flow GenerationConsistent positive FCF and near 1:1 cash conversion of net income provide durable funding for claims, retrocession, and capital returns without frequent external financing. This strengthens financial flexibility and resilience across underwriting cycles.
Bears Say
Sharp Revenue ContractionA pronounced revenue decline erodes scale and diversifying revenue streams, limiting the firm’s ability to spread fixed costs and absorb large-loss variability. Over months this can constrain investment in growth initiatives and reduce underwriting leverage in key markets.
Life & Health Portfolio StressMaterial adverse assumption updates and claim volatility in Life & Health create earnings unpredictability and reserve pressure. Structurally, this segment can drag group returns, complicate capital planning and require pricing or product redesign to restore sustainable profitability.
Low Equity Ratio / Reliance On LiabilitiesA relatively low equity ratio increases sensitivity to underwriting losses and market shocks; reliance on liabilities can raise solvency risk under stress. Over several months this may necessitate capital management actions or higher reinsurance costs to maintain regulatory and rating agency metrics.
Swiss Re News
SSREY FAQ
What was Swiss Re’s price range in the past 12 months?
Swiss Re lowest stock price was $37.67 and its highest was $48.50 in the past 12 months.
What is Swiss Re’s market cap?
Swiss Re’s market cap is $45.10B.
When is Swiss Re’s upcoming earnings report date?
Swiss Re’s upcoming earnings report date is May 07, 2026 which is in 61 days.
How were Swiss Re’s earnings last quarter?
Swiss Re released its earnings results on Feb 27, 2026. The company reported $0.57 earnings per share for the quarter, missing the consensus estimate of $0.609 by -$0.039.
Is Swiss Re overvalued?
According to Wall Street analysts Swiss Re’s price is currently Overvalued.
Does Swiss Re pay dividends?
Swiss Re pays a Annually dividend of $1.838 which represents an annual dividend yield of 4.42%. See more information on Swiss Re dividends here
What is Swiss Re’s EPS estimate?
Swiss Re’s EPS estimate is 0.91.
How many shares outstanding does Swiss Re have?
Swiss Re has 1,195,046,900 shares outstanding.
What happened to Swiss Re’s price movement after its last earnings report?
Swiss Re reported an EPS of $0.57 in its last earnings report, missing expectations of $0.609. Following the earnings report the stock price went up 4.371%.
Which hedge fund is a major shareholder of Swiss Re?
Currently, no hedge funds are holding shares in SSREY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Swiss Re Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 31.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.05%
12-Months-Change
Fundamentals
Return on Equity
17.36%
Trailing 12-Months
Asset Growth
6.13%
Trailing 12-Months
Company Description
Swiss Re
Swiss Re (SSREY) is a leading global reinsurance and insurance company headquartered in Zurich, Switzerland. Established in 1863, Swiss Re operates primarily in the reinsurance sector, providing a wide range of products and services, including property and casualty reinsurance, life and health reinsurance, and insurance solutions. The company also offers risk management and advisory services, catering to clients in various industries worldwide, including financial services, healthcare, and natural resources.
SSREY Company Deck
SSREY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a broadly positive picture: Swiss Re delivered record earnings (USD 4.8 billion) and strong underwriting results (P&C Re combined ratio 79.4%), executed tangible capital returns (9% higher ordinary dividend plus USD 1.5 billion in buybacks) and strengthened reserves and resilience (loss picks +4.6%, added reserves, IBNR reallocation). Major negatives were concentrated in Life & Health where assumption updates and adverse experience reduced 2025 earnings (approx. USD 950 million combined impact across updates and experience), a meaningful top-line decline (USD 43.1bn vs USD 45.6bn) and increased direct nat cat exposure following reduced retrocession. On balance the positive operational and capital achievements, clear cost-savings targets and strong solvency metrics outweigh the lower‑order and addressable headwinds, supporting a constructive outlook.View all SSREY earnings summariesTechnical Analysis
Everest Group
―
Reinsurance Group
―
Renaissancere Holdings
―
SiriusPoint
―
Hamilton Insurance Group, Ltd. Class B
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---